Patents by Inventor Miho Takada

Miho Takada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230181614
    Abstract: The invention provides a method for improving attention of a healthy human subject by administering an effective amount of citidine-5?-diphosphocholine or a salt thereof to a healthy human subject.
    Type: Application
    Filed: December 21, 2022
    Publication date: June 15, 2023
    Applicant: KYOWA HAKKO BIO CO., LTD.
    Inventors: Deborah Yurgelun-Todd, Perry Renshaw, Miho Takada, Takeshi Ikeda, Masahiko Morita
  • Patent number: 11583546
    Abstract: A method of improving both motor function and cognitive function of healthy human subjects through administration of citicoline or its salt in high dosage or low dosage for a period of time, resulting in improved motor function and cognitive function.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: February 21, 2023
    Assignee: KYOWA HAKKO BIO CO., LTD.
    Inventors: Deborah Yurgelun-Todd, Perry Renshaw, Miho Takada, Takeshi Ikeda, Masahiko Morita
  • Publication number: 20170049796
    Abstract: A method of improving both motor function and cognitive function of healthy human subjects through administration of citicoline or its salt in high dosage or low dosage for a period of time, resulting in improved motor function and cognitive function.
    Type: Application
    Filed: April 30, 2015
    Publication date: February 23, 2017
    Applicant: KYOWA HAKKO BIO CO., LTD.
    Inventors: Deborah Yurgelun-Todd, Perry Renshaw, Miho Takada, Takeshi Ikeda, Masahiko Morita
  • Patent number: 7932288
    Abstract: There has been a demand in the marketplace for medicines, functional foods and so on which can relieve subjective symptoms of fatigue in persons having these subjective symptoms, and enabling the persons to have productive days. That is, an object of the present invention is to provide a composition for relieving subjective symptoms of fatigue. According to the present invention, a safe and effective composition for relieving subjective symptoms of fatigue which contains ornithine or a salt thereof as an active ingredient can be provided.
    Type: Grant
    Filed: October 4, 2006
    Date of Patent: April 26, 2011
    Assignee: Kyowa Hakko Bio Co., Ltd.
    Inventors: Miho Komatsu, Koji Morishita, Akemi Ogawa, Goro Hori, Miho Takada
  • Publication number: 20090232917
    Abstract: There has been a demand in the marketplace for medicines, functional foods and so on which can relieve subjective symptoms of fatigue in persons having these subjective symptoms, and enabling the persons to have productive days. That is, an object of the present invention is to provide a composition for relieving subjective symptoms of fatigue. According to the present invention, a safe and effective composition for relieving subjective symptoms of fatigue which contains ornithine or a salt thereof as an active ingredient can be provided.
    Type: Application
    Filed: October 4, 2006
    Publication date: September 17, 2009
    Applicant: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Miho Komatsu, Koji Morishita, Akemi Ogawa, Goro Hori, Miho Takada
  • Patent number: 7485662
    Abstract: An object of the present invention is to provide a therapeutic agent for diabetes mellitus or insulin resistance improving agent, or to provide foods and drinks, food and drink additives, and feeds or feed additives for treating diabetes mellitus or improving insulin diabetes. In order to achieve such an object, the present invention provides a therapeutic agent for diabetes mellitus and insulin resistance improving agent comprising hydroxyproline, a hydroxyproline derivative or a pharmaceutically acceptable salt thereof or foods and drinks, food and drink additives, feeds or feed additives for treatment of diabetes mellitus or improvement of insulin resistance comprising the same.
    Type: Grant
    Filed: March 19, 2004
    Date of Patent: February 3, 2009
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Toshikazu Kamiya, Akio Shirai, Miho Takada, Fumiko Ogino
  • Publication number: 20060173066
    Abstract: An object of the present invention is to provide a therapeutic agent for diabetes mellitus or insulin resistance improving agent, or to provide foods and drinks, food and drink additives, and feeds or feed additives for treating diabetes mellitus or improving insulin diabetes. In order to achieve such an object, the present invention provides a therapeutic agent for diabetes mellitus and insulin resistance improving agent comprising hydroxyproline, a hydroxyproline derivative or a pharmaceutically acceptable salt thereof or foods and drinks, food and drink additives, feeds or feed additives for treatment of diabetes mellitus or improvement of insulin resistance comprising the same.
    Type: Application
    Filed: March 19, 2004
    Publication date: August 3, 2006
    Applicant: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Toshikazu Kamiya, Akio Shirai, Miho Takada, Fumiko Ogino
  • Patent number: 6946451
    Abstract: Provided are a method for promoting insulin secretion, a method for suppressing the elevation of a blood glucose level, a method for ameliorating diabetes mellitus, a method for promoting growth of an animal, and a method for increasing an insulin level in breast milk. These methods comprising administering at least one member selected from the group consisting of a di- or a higher saccharide containing galactose, a derivative thereof, a saccharide containing N-acetylneuraminic acid, and a derivative thereof, to a patient in need thereof or an animal.
    Type: Grant
    Filed: February 3, 2003
    Date of Patent: September 20, 2005
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Miho Takada, Toshikazu Kamiya, Tetsuo Endo, Satoshi Koizumi
  • Publication number: 20040265426
    Abstract: According to the process, miso where a lipid metabolism improving action, particularly, a cholesterol lowering action, is potentiated is obtained. There is provided a process for producing miso comprising subjecting a prepared mixture of materials for miso to aging followed by a heating treatment preferably at 70 to 95° C. (substance temperature) for 3 to 40 minutes and then adding thereto phospholipid so as to make its content based on 100 parts by weight of the resulting dried miso 0.4 to 2.0 part(s) by weight.
    Type: Application
    Filed: June 14, 2004
    Publication date: December 30, 2004
    Applicants: KYOWA HAKKO KOGYO CO., LTD., MARUKOME CO., LTD
    Inventors: Yasushi Sakai, Ayako Muromachi, Miho Takada, Mika Hashimoto, Takahiro Hara, Noriyoshi Ichijo, Takehiro Nishida
  • Publication number: 20030181401
    Abstract: Provided are a method for promoting insulin secretion, a method for suppressing the elevation of a blood glucose level, a method for ameliorating diabetes mellitus, a method for promoting growth of an animal, and a method for increasing an insulin level in breast milk. These methods comprising administering at least one member selected from the group consisting of a di- or a higher saccharide containing galactose, a derivative thereof, a saccharide containing N-acetylneuraminic acid, and a derivative thereof, to a patient in need thereof or an animal.
    Type: Application
    Filed: February 3, 2003
    Publication date: September 25, 2003
    Applicant: KYOWA HAKKO KOGYO CO., LTD.
    Inventors: Miho Takada, Toshikazu Kamiya, Tetsuo Endo, Satoshi Koizumi